Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP4
|
ENSG00000105866.9 | Sp4 transcription factor |
PML
|
ENSG00000140464.15 | PML nuclear body scaffold |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PML | hg19_v2_chr15_+_74287009_74287018 | -0.52 | 7.2e-03 | Click! |
SP4 | hg19_v2_chr7_+_21467642_21467671 | -0.10 | 6.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_77155856 | 12.16 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr18_+_77160282 | 9.79 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr14_-_105635090 | 9.68 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr13_-_77460525 | 9.15 |
ENST00000377474.2
ENST00000317765.2 |
KCTD12
|
potassium channel tetramerization domain containing 12 |
chr18_+_77155942 | 8.83 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr1_+_61548225 | 8.19 |
ENST00000371187.3
|
NFIA
|
nuclear factor I/A |
chr13_-_72440901 | 8.15 |
ENST00000359684.2
|
DACH1
|
dachshund homolog 1 (Drosophila) |
chr11_-_33891362 | 7.92 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr9_+_139606983 | 7.91 |
ENST00000371692.4
|
FAM69B
|
family with sequence similarity 69, member B |
chr12_+_123319973 | 7.70 |
ENST00000253083.4
|
HIP1R
|
huntingtin interacting protein 1 related |
chr14_-_91526462 | 6.80 |
ENST00000536315.2
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr22_+_51112800 | 6.78 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr8_+_27491381 | 6.74 |
ENST00000337221.4
|
SCARA3
|
scavenger receptor class A, member 3 |
chr4_+_41362796 | 6.65 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr1_+_25944341 | 6.56 |
ENST00000263979.3
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr14_+_24867992 | 6.52 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr1_+_61547894 | 6.52 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr19_+_1407733 | 6.33 |
ENST00000592453.1
|
DAZAP1
|
DAZ associated protein 1 |
chr3_+_39851094 | 6.31 |
ENST00000302541.6
|
MYRIP
|
myosin VIIA and Rab interacting protein |
chrX_+_9754461 | 6.30 |
ENST00000380913.3
|
SHROOM2
|
shroom family member 2 |
chr2_+_7057523 | 6.27 |
ENST00000320892.6
|
RNF144A
|
ring finger protein 144A |
chr9_-_132805430 | 6.21 |
ENST00000446176.2
ENST00000355681.3 ENST00000420781.1 |
FNBP1
|
formin binding protein 1 |
chr4_+_156588806 | 6.18 |
ENST00000513574.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr3_+_37903432 | 5.93 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr8_+_37654693 | 5.81 |
ENST00000412232.2
|
GPR124
|
G protein-coupled receptor 124 |
chr13_-_110438914 | 5.79 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr1_+_78511586 | 5.72 |
ENST00000370759.3
|
GIPC2
|
GIPC PDZ domain containing family, member 2 |
chr1_-_231175964 | 5.52 |
ENST00000366654.4
|
FAM89A
|
family with sequence similarity 89, member A |
chr18_-_22932080 | 5.51 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
chr12_+_20522179 | 5.50 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr17_+_81037473 | 5.46 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
chr3_-_15901278 | 5.35 |
ENST00000399451.2
|
ANKRD28
|
ankyrin repeat domain 28 |
chr11_-_2906979 | 5.22 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr19_-_19051993 | 5.21 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr11_+_43964055 | 5.17 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
chr19_-_19051927 | 5.17 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
chr1_+_61548374 | 5.12 |
ENST00000485903.2
ENST00000371185.2 ENST00000371184.2 |
NFIA
|
nuclear factor I/A |
chr2_+_173600671 | 5.09 |
ENST00000409036.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr4_-_102268484 | 5.05 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr6_+_142623063 | 4.96 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
chr5_+_121647877 | 4.92 |
ENST00000514497.2
ENST00000261367.7 |
SNCAIP
|
synuclein, alpha interacting protein |
chr1_-_234745234 | 4.90 |
ENST00000366610.3
ENST00000366609.3 |
IRF2BP2
|
interferon regulatory factor 2 binding protein 2 |
chr14_-_89883412 | 4.88 |
ENST00000557258.1
|
FOXN3
|
forkhead box N3 |
chr2_+_173600565 | 4.85 |
ENST00000397081.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr2_+_173600514 | 4.84 |
ENST00000264111.6
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr8_+_37654424 | 4.83 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
chr5_+_121647924 | 4.83 |
ENST00000414317.2
|
SNCAIP
|
synuclein, alpha interacting protein |
chr7_-_38671098 | 4.82 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr19_-_291365 | 4.82 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr2_+_191513789 | 4.81 |
ENST00000409581.1
|
NAB1
|
NGFI-A binding protein 1 (EGR1 binding protein 1) |
chr18_+_59992527 | 4.80 |
ENST00000586569.1
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
chr5_+_121647764 | 4.80 |
ENST00000261368.8
ENST00000379533.2 ENST00000379536.2 ENST00000379538.3 |
SNCAIP
|
synuclein, alpha interacting protein |
chr18_+_59992514 | 4.79 |
ENST00000269485.7
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
chr17_+_68165657 | 4.71 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
chr1_+_65210772 | 4.68 |
ENST00000371072.4
ENST00000294428.3 |
RAVER2
|
ribonucleoprotein, PTB-binding 2 |
chr7_-_38670957 | 4.68 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
chr15_-_65067773 | 4.67 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
chr9_+_133971909 | 4.63 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
chr9_+_133971863 | 4.62 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr10_-_81205373 | 4.59 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr10_-_125851961 | 4.52 |
ENST00000346248.5
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr11_+_125034586 | 4.51 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
chr5_+_121647386 | 4.51 |
ENST00000542191.1
ENST00000506272.1 ENST00000508681.1 ENST00000509154.2 |
SNCAIP
|
synuclein, alpha interacting protein |
chr4_+_156588350 | 4.50 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr10_+_35416090 | 4.50 |
ENST00000354759.3
|
CREM
|
cAMP responsive element modulator |
chr21_+_46494466 | 4.47 |
ENST00000539173.1
ENST00000389863.4 ENST00000348831.4 ENST00000437626.1 |
ADARB1
|
adenosine deaminase, RNA-specific, B1 |
chr3_+_20081515 | 4.45 |
ENST00000263754.4
|
KAT2B
|
K(lysine) acetyltransferase 2B |
chr19_-_3029011 | 4.44 |
ENST00000590536.1
ENST00000587137.1 ENST00000455444.2 ENST00000262953.6 |
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr19_-_14201507 | 4.40 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chrX_+_9983602 | 4.39 |
ENST00000380861.4
|
WWC3
|
WWC family member 3 |
chr9_-_14314066 | 4.38 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr8_+_27491572 | 4.36 |
ENST00000301904.3
|
SCARA3
|
scavenger receptor class A, member 3 |
chr6_+_126112074 | 4.36 |
ENST00000453302.1
ENST00000417494.1 ENST00000229634.9 |
NCOA7
|
nuclear receptor coactivator 7 |
chr4_+_1003742 | 4.36 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
chr7_-_11871815 | 4.33 |
ENST00000423059.4
|
THSD7A
|
thrombospondin, type I, domain containing 7A |
chr2_-_190445499 | 4.27 |
ENST00000261024.2
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1 |
chr1_+_84543734 | 4.25 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr20_-_47444420 | 4.22 |
ENST00000371941.3
ENST00000396220.1 |
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
chr9_-_139581848 | 4.20 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr14_-_100772862 | 4.20 |
ENST00000359232.3
|
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
chr7_+_74072288 | 4.20 |
ENST00000443166.1
|
GTF2I
|
general transcription factor IIi |
chr6_+_84743436 | 4.19 |
ENST00000257776.4
|
MRAP2
|
melanocortin 2 receptor accessory protein 2 |
chr8_-_28243590 | 4.15 |
ENST00000523095.1
ENST00000522795.1 |
ZNF395
|
zinc finger protein 395 |
chrX_+_135229731 | 4.14 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
chr4_-_102267953 | 4.14 |
ENST00000523694.2
ENST00000507176.1 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr8_+_86089619 | 4.13 |
ENST00000256117.5
ENST00000416274.2 |
E2F5
|
E2F transcription factor 5, p130-binding |
chr20_-_62462566 | 4.09 |
ENST00000245663.4
ENST00000302995.2 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
chr2_-_101767715 | 4.06 |
ENST00000376840.4
ENST00000409318.1 |
TBC1D8
|
TBC1 domain family, member 8 (with GRAM domain) |
chr18_-_500692 | 4.03 |
ENST00000400256.3
|
COLEC12
|
collectin sub-family member 12 |
chr4_-_102268628 | 4.02 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr10_+_35415978 | 4.01 |
ENST00000429130.3
ENST00000469949.2 ENST00000460270.1 |
CREM
|
cAMP responsive element modulator |
chr14_-_30396802 | 4.00 |
ENST00000415220.2
|
PRKD1
|
protein kinase D1 |
chr15_+_57668695 | 3.91 |
ENST00000281282.5
|
CGNL1
|
cingulin-like 1 |
chr9_-_140196703 | 3.91 |
ENST00000356628.2
|
NRARP
|
NOTCH-regulated ankyrin repeat protein |
chr9_-_80646374 | 3.89 |
ENST00000286548.4
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide |
chr6_+_30852130 | 3.88 |
ENST00000428153.2
ENST00000376568.3 ENST00000452441.1 ENST00000515219.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr9_-_139581875 | 3.86 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr11_+_68080077 | 3.85 |
ENST00000294304.7
|
LRP5
|
low density lipoprotein receptor-related protein 5 |
chr6_+_17393888 | 3.83 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr12_+_3186521 | 3.83 |
ENST00000537971.1
ENST00000011898.5 |
TSPAN9
|
tetraspanin 9 |
chr7_-_132262060 | 3.83 |
ENST00000359827.3
|
PLXNA4
|
plexin A4 |
chr18_+_11981427 | 3.83 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr19_-_291133 | 3.80 |
ENST00000327790.3
|
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr11_-_45687128 | 3.79 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr16_+_81812863 | 3.79 |
ENST00000359376.3
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
chr2_+_191513959 | 3.77 |
ENST00000337386.5
ENST00000357215.5 |
NAB1
|
NGFI-A binding protein 1 (EGR1 binding protein 1) |
chr14_-_100772767 | 3.74 |
ENST00000392908.3
ENST00000539621.1 |
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
chr8_+_120220561 | 3.73 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr11_-_2160611 | 3.72 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr1_+_65886244 | 3.71 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
chrX_+_135229600 | 3.69 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
chr11_+_849816 | 3.68 |
ENST00000527644.1
|
TSPAN4
|
tetraspanin 4 |
chr16_-_30107491 | 3.67 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
chr3_-_124774802 | 3.63 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
chr17_-_42276574 | 3.63 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr17_-_65989623 | 3.62 |
ENST00000449250.2
ENST00000536693.1 ENST00000334461.7 |
C17orf58
|
chromosome 17 open reading frame 58 |
chr9_-_14313893 | 3.62 |
ENST00000380921.3
ENST00000380959.3 |
NFIB
|
nuclear factor I/B |
chr6_+_142622991 | 3.60 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
chr8_+_86089460 | 3.60 |
ENST00000418930.2
|
E2F5
|
E2F transcription factor 5, p130-binding |
chr2_+_85360499 | 3.59 |
ENST00000282111.3
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box) |
chr8_-_28243934 | 3.58 |
ENST00000521185.1
ENST00000520290.1 ENST00000344423.5 |
ZNF395
|
zinc finger protein 395 |
chr13_-_114567034 | 3.58 |
ENST00000327773.6
ENST00000357389.3 |
GAS6
|
growth arrest-specific 6 |
chr1_+_33005020 | 3.57 |
ENST00000373510.4
ENST00000316459.4 |
ZBTB8A
|
zinc finger and BTB domain containing 8A |
chr2_-_240322643 | 3.56 |
ENST00000345617.3
|
HDAC4
|
histone deacetylase 4 |
chr9_-_77703056 | 3.54 |
ENST00000376811.1
|
NMRK1
|
nicotinamide riboside kinase 1 |
chr12_+_53440753 | 3.53 |
ENST00000379902.3
|
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr6_-_13711773 | 3.52 |
ENST00000011619.3
|
RANBP9
|
RAN binding protein 9 |
chr2_+_238536207 | 3.51 |
ENST00000308482.9
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr14_-_92414055 | 3.50 |
ENST00000342058.4
|
FBLN5
|
fibulin 5 |
chr14_+_100259666 | 3.49 |
ENST00000262233.6
ENST00000334192.4 |
EML1
|
echinoderm microtubule associated protein like 1 |
chr14_+_103058948 | 3.49 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr6_-_16761678 | 3.48 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr10_-_126849588 | 3.47 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
chr13_-_107187462 | 3.44 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chr11_+_44748361 | 3.43 |
ENST00000533202.1
ENST00000533080.1 ENST00000520358.2 ENST00000520999.2 |
TSPAN18
|
tetraspanin 18 |
chrX_+_152240819 | 3.43 |
ENST00000421798.3
ENST00000535416.1 |
PNMA6C
PNMA6A
|
paraneoplastic Ma antigen family member 6C paraneoplastic Ma antigen family member 6A |
chr6_+_53659746 | 3.41 |
ENST00000370888.1
|
LRRC1
|
leucine rich repeat containing 1 |
chr1_-_208084729 | 3.41 |
ENST00000310833.7
ENST00000356522.4 |
CD34
|
CD34 molecule |
chr1_-_209979375 | 3.41 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr20_+_34742650 | 3.41 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr9_-_77703115 | 3.40 |
ENST00000361092.4
ENST00000376808.4 |
NMRK1
|
nicotinamide riboside kinase 1 |
chr13_-_45150392 | 3.39 |
ENST00000501704.2
|
TSC22D1
|
TSC22 domain family, member 1 |
chr12_+_57482877 | 3.39 |
ENST00000342556.6
ENST00000357680.4 |
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr17_-_34122596 | 3.38 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr1_+_33207381 | 3.38 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
chr9_-_14313641 | 3.37 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
chr7_+_24613034 | 3.36 |
ENST00000409761.1
ENST00000396475.2 |
MPP6
|
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
chr1_-_22263790 | 3.36 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
chrX_-_117250740 | 3.35 |
ENST00000371882.1
ENST00000540167.1 ENST00000545703.1 |
KLHL13
|
kelch-like family member 13 |
chr5_+_68788594 | 3.34 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
chr11_+_64002292 | 3.32 |
ENST00000426086.2
|
VEGFB
|
vascular endothelial growth factor B |
chr9_+_82188077 | 3.31 |
ENST00000425506.1
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr11_-_63536113 | 3.29 |
ENST00000433688.1
ENST00000546282.2 |
C11orf95
RP11-466C23.4
|
chromosome 11 open reading frame 95 RP11-466C23.4 |
chr17_-_42277203 | 3.27 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr18_+_11981547 | 3.26 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr1_+_61547405 | 3.26 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
chr9_+_131314859 | 3.25 |
ENST00000358161.5
ENST00000372731.4 ENST00000372739.3 |
SPTAN1
|
spectrin, alpha, non-erythrocytic 1 |
chr7_-_32931623 | 3.25 |
ENST00000452926.1
|
KBTBD2
|
kelch repeat and BTB (POZ) domain containing 2 |
chr8_-_101322132 | 3.24 |
ENST00000523481.1
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
chr15_-_52587945 | 3.24 |
ENST00000443683.2
ENST00000558479.1 ENST00000261839.7 |
MYO5C
|
myosin VC |
chr2_+_242498135 | 3.23 |
ENST00000318407.3
|
BOK
|
BCL2-related ovarian killer |
chr4_+_1873100 | 3.22 |
ENST00000508803.1
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
chr7_+_94023873 | 3.22 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr9_-_13279406 | 3.21 |
ENST00000546205.1
|
MPDZ
|
multiple PDZ domain protein |
chr2_+_48757278 | 3.21 |
ENST00000404752.1
ENST00000406226.1 |
STON1
|
stonin 1 |
chr17_+_31254892 | 3.20 |
ENST00000394642.3
ENST00000579849.1 |
TMEM98
|
transmembrane protein 98 |
chr1_-_33168336 | 3.18 |
ENST00000373484.3
|
SYNC
|
syncoilin, intermediate filament protein |
chrX_+_135229559 | 3.16 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
chr16_-_46864955 | 3.16 |
ENST00000565112.1
|
C16orf87
|
chromosome 16 open reading frame 87 |
chr20_-_62680984 | 3.15 |
ENST00000340356.7
|
SOX18
|
SRY (sex determining region Y)-box 18 |
chr6_-_13487784 | 3.15 |
ENST00000379287.3
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr3_-_18466787 | 3.13 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr3_+_32147997 | 3.13 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chr13_-_114898016 | 3.13 |
ENST00000542651.1
ENST00000334062.7 |
RASA3
|
RAS p21 protein activator 3 |
chr11_+_64001962 | 3.13 |
ENST00000309422.2
|
VEGFB
|
vascular endothelial growth factor B |
chr5_-_111093406 | 3.10 |
ENST00000379671.3
|
NREP
|
neuronal regeneration related protein |
chr12_+_57482665 | 3.09 |
ENST00000300131.3
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr7_+_79764104 | 3.06 |
ENST00000351004.3
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr11_-_2160180 | 3.05 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr9_-_14314566 | 3.05 |
ENST00000397579.2
|
NFIB
|
nuclear factor I/B |
chr1_+_25943959 | 3.04 |
ENST00000374332.4
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr13_+_21277482 | 3.02 |
ENST00000304920.3
|
IL17D
|
interleukin 17D |
chr12_+_44229846 | 3.01 |
ENST00000551577.1
ENST00000266534.3 |
TMEM117
|
transmembrane protein 117 |
chr14_-_54420133 | 3.01 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
chr14_+_71374433 | 3.01 |
ENST00000439984.3
|
PCNX
|
pecanex homolog (Drosophila) |
chr15_+_63569785 | 2.99 |
ENST00000380343.4
ENST00000560353.1 |
APH1B
|
APH1B gamma secretase subunit |
chr22_-_22090043 | 2.99 |
ENST00000403503.1
|
YPEL1
|
yippee-like 1 (Drosophila) |
chr16_+_14165160 | 2.99 |
ENST00000574998.1
ENST00000571589.1 ENST00000574045.1 |
MKL2
|
MKL/myocardin-like 2 |
chr12_+_3068544 | 2.98 |
ENST00000540314.1
ENST00000536826.1 ENST00000359864.2 |
TEAD4
|
TEA domain family member 4 |
chr19_-_11373128 | 2.97 |
ENST00000294618.7
|
DOCK6
|
dedicator of cytokinesis 6 |
chr10_+_35415719 | 2.97 |
ENST00000474362.1
ENST00000374721.3 |
CREM
|
cAMP responsive element modulator |
chr14_+_100437780 | 2.97 |
ENST00000402714.2
|
EVL
|
Enah/Vasp-like |
chr16_+_81478775 | 2.97 |
ENST00000537098.3
|
CMIP
|
c-Maf inducing protein |
chr9_-_111775772 | 2.96 |
ENST00000325580.6
ENST00000374593.4 ENST00000374595.4 ENST00000325551.4 |
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1 |
chr1_-_209979465 | 2.96 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
chr1_+_33722080 | 2.95 |
ENST00000483388.1
ENST00000539719.1 |
ZNF362
|
zinc finger protein 362 |
chr4_+_156588115 | 2.94 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr9_-_13279563 | 2.94 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
chr6_+_30851840 | 2.91 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr15_-_71055769 | 2.90 |
ENST00000539319.1
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
3.2 | 9.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
3.1 | 18.6 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
2.6 | 7.9 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
2.6 | 10.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.5 | 17.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
2.2 | 10.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
2.0 | 11.9 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
1.9 | 5.8 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
1.9 | 9.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.6 | 11.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.6 | 9.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.6 | 6.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
1.6 | 6.2 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
1.5 | 6.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
1.5 | 6.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
1.5 | 4.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
1.4 | 1.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.4 | 4.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.4 | 4.3 | GO:0070839 | divalent metal ion export(GO:0070839) |
1.4 | 4.1 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
1.4 | 5.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.3 | 1.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.3 | 3.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.3 | 5.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.3 | 3.8 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.2 | 8.7 | GO:0097338 | response to clozapine(GO:0097338) |
1.2 | 6.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.2 | 9.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 4.7 | GO:0009447 | putrescine catabolic process(GO:0009447) |
1.2 | 6.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.2 | 4.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
1.1 | 1.1 | GO:0072179 | nephric duct formation(GO:0072179) |
1.1 | 3.4 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
1.1 | 10.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 3.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.1 | 3.2 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
1.1 | 4.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
1.1 | 8.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.1 | 6.4 | GO:0030421 | defecation(GO:0030421) |
1.1 | 3.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
1.1 | 3.2 | GO:0097187 | dentinogenesis(GO:0097187) |
1.0 | 3.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.0 | 1.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
1.0 | 4.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.0 | 4.1 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
1.0 | 3.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.0 | 4.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.0 | 1.0 | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
1.0 | 5.8 | GO:0032252 | secretory granule localization(GO:0032252) |
1.0 | 3.9 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
1.0 | 4.8 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
1.0 | 2.9 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.9 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.9 | 0.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 0.9 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.9 | 2.8 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.9 | 0.9 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.9 | 4.6 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.9 | 2.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.9 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
0.9 | 3.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.9 | 0.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.9 | 6.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.9 | 2.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 3.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.9 | 3.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.9 | 2.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.9 | 2.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.9 | 2.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.9 | 2.6 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.9 | 6.9 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 10.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.9 | 3.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.8 | 2.5 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.8 | 7.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.8 | 4.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.8 | 2.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.8 | 3.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.8 | 3.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.8 | 0.8 | GO:0071506 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
0.8 | 2.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 3.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.8 | 2.4 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.8 | 7.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.8 | 0.8 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.8 | 7.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 1.6 | GO:0001300 | chronological cell aging(GO:0001300) |
0.8 | 17.6 | GO:0072189 | ureter development(GO:0072189) |
0.8 | 2.3 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.8 | 2.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.8 | 3.0 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.8 | 2.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.8 | 2.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.7 | 2.9 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.7 | 6.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 2.9 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.7 | 2.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.7 | 4.3 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.7 | 0.7 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.7 | 0.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.7 | 4.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.7 | 1.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.7 | 2.1 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.7 | 4.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 6.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.7 | 2.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.7 | 3.4 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.7 | 2.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 3.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.7 | 5.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.7 | 2.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.7 | 2.0 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.7 | 3.3 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.7 | 2.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.7 | 5.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.7 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 3.9 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.6 | 2.6 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.6 | 1.9 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.6 | 6.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.6 | 8.1 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.6 | 3.7 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.6 | 3.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 23.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.6 | 4.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 0.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.6 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 3.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 2.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.6 | 30.8 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.6 | 1.7 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.6 | 1.7 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.6 | 2.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 15.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.6 | 1.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.6 | 2.8 | GO:0019075 | virus maturation(GO:0019075) |
0.6 | 2.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.6 | 2.2 | GO:0060849 | radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.6 | 1.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.6 | 3.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 2.2 | GO:0060025 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) |
0.6 | 1.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 1.7 | GO:0070541 | response to platinum ion(GO:0070541) |
0.6 | 2.2 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.5 | 2.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 3.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 4.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.5 | 7.1 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 1.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 8.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.5 | 2.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.5 | 4.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 11.3 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 1.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 2.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.5 | 1.6 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 1.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.0 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.5 | 2.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.5 | 2.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 0.5 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.5 | 3.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 2.6 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 2.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.5 | 4.1 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 1.0 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.5 | 6.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 2.0 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 1.5 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.5 | 2.0 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.5 | 5.0 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 1.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 8.3 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 5.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.5 | 4.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.5 | 2.9 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.5 | 1.5 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.5 | 1.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.5 | 1.4 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.5 | 1.4 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 1.4 | GO:0034059 | response to anoxia(GO:0034059) |
0.5 | 4.2 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.5 | 2.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 6.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 1.8 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.5 | 1.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 1.4 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.5 | 6.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.5 | 2.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.5 | 2.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.5 | 9.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.5 | 1.4 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.5 | 2.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.5 | 1.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.5 | 0.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 1.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 5.8 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 2.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.4 | 4.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.3 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.4 | 1.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.8 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 0.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.4 | 0.4 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.4 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 6.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 2.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 1.3 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.4 | 1.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.4 | 2.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.4 | 1.3 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.4 | 1.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 0.9 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.4 | 1.7 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.4 | 2.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.4 | 2.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.7 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.4 | 2.1 | GO:0016129 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.4 | 2.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 2.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 3.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 2.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 2.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 | 4.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 7.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 2.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.2 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.4 | 1.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 1.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 1.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.4 | 2.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.4 | 3.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 2.3 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.4 | 0.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.4 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 1.9 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.4 | 1.5 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.4 | 0.8 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.4 | 1.2 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.4 | 0.4 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.4 | 1.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 1.5 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.4 | 0.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 0.8 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.4 | 0.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.4 | 0.8 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
0.4 | 9.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.4 | 3.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.4 | 0.4 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 1.5 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 1.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.4 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 1.1 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.4 | 1.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.4 | 0.4 | GO:0043335 | protein unfolding(GO:0043335) |
0.4 | 1.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 7.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 0.7 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.4 | 0.7 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.4 | 0.4 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.4 | 9.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.1 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.4 | 2.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 0.7 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.4 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.4 | 3.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 0.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.4 | 1.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.7 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.4 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 8.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.4 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.3 | 2.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 5.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 1.4 | GO:0015853 | adenine transport(GO:0015853) |
0.3 | 0.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 3.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 1.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.3 | 0.3 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 1.0 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.3 | 2.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 1.0 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 3.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 1.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 1.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 7.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 2.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.3 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 5.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 2.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 1.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.3 | 3.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 1.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 1.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 1.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 4.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.3 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.3 | 3.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 0.3 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
0.3 | 0.9 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.3 | 3.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 0.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.3 | 0.9 | GO:0006272 | leading strand elongation(GO:0006272) |
0.3 | 0.9 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
0.3 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 2.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.9 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 2.4 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 2.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.3 | GO:0034758 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.3 | 0.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 1.8 | GO:0006574 | valine catabolic process(GO:0006574) |
0.3 | 4.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.3 | 1.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 3.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 2.4 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 0.9 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
0.3 | 3.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 2.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 0.3 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.3 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 4.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 0.8 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.3 | 1.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.3 | 2.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.3 | 1.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 6.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.3 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.3 | 0.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.8 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 0.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 2.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 6.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.6 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.3 | 1.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 2.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 1.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 1.0 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.3 | 3.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.3 | 0.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) regulation of secretion of lysosomal enzymes(GO:0090182) |
0.3 | 0.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 0.3 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.3 | 0.8 | GO:0070781 | response to biotin(GO:0070781) |
0.3 | 0.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.3 | 1.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 1.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 0.8 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.3 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.3 | 3.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 1.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 11.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 1.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 2.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 1.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 0.7 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.2 | 1.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 1.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 0.7 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 1.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 3.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.2 | 1.0 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.2 | 4.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 2.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 10.8 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 4.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.7 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 6.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.2 | 1.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.2 | 3.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.7 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.2 | 1.8 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 1.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 12.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.2 | 0.7 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 0.9 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 0.7 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.2 | 1.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 1.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 1.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.2 | 3.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 0.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 1.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 4.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.6 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.2 | 1.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.2 | 6.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.4 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.2 | 1.3 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 0.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 0.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.2 | 0.6 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 2.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.2 | 0.8 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.2 | 0.2 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
0.2 | 0.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 1.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.2 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 1.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 2.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 2.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 1.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 4.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 0.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.2 | 0.2 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.2 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.2 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.2 | 1.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.2 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 1.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 1.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 1.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.2 | 0.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.9 | GO:0009111 | vitamin catabolic process(GO:0009111) |
0.2 | 1.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 2.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 1.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 2.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 1.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 3.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 1.8 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 2.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 2.6 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 2.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.2 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
0.2 | 1.5 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.9 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 1.3 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.2 | 0.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 2.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.4 | GO:0009386 | translational attenuation(GO:0009386) |
0.2 | 0.9 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.2 | 1.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 0.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.2 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.9 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.2 | 0.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.2 | 4.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.2 | 0.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 1.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.2 | 0.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 4.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.2 | 0.5 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.5 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.2 | 0.7 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.3 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.2 | 0.5 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.2 | 2.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 1.9 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 1.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.8 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 1.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.2 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 0.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.2 | 0.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.2 | 2.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 7.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 3.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 1.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.8 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) regulation of rubidium ion transmembrane transporter activity(GO:2000686) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.2 | 0.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.2 | 0.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 5.0 | GO:0097009 | energy homeostasis(GO:0097009) |
0.2 | 2.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.5 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.1 | 1.6 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 1.0 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 1.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.6 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.4 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
0.1 | 1.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 2.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 3.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 3.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 3.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 3.0 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.3 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.4 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.4 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 2.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 5.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 1.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.7 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.1 | 0.6 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.4 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 0.4 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.1 | 0.7 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 1.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 2.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.8 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 2.0 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.9 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 1.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 4.9 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.1 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.8 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 1.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 4.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 1.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 4.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.4 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 0.5 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 3.6 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 1.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 1.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.5 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.7 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 3.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.5 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 1.0 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.5 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 1.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 2.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 2.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 2.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 1.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.8 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 1.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 2.6 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.4 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.1 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 1.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.8 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.2 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.1 | 1.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 1.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 1.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 0.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.3 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 1.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 3.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.1 | 0.2 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 2.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.4 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 0.5 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 2.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.3 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.1 | 0.6 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 1.6 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.1 | 2.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 1.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.4 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.1 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.5 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 1.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.9 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 1.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.5 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.1 | 0.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 1.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 7.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 2.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.3 | GO:0030474 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.1 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 3.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 2.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 5.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.3 | GO:0051257 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
0.1 | 0.1 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.1 | 0.3 | GO:0035572 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 1.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.5 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 1.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 2.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 2.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 7.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 2.0 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.1 | 1.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.2 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
0.1 | 2.9 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.8 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 1.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 3.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.2 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.2 | GO:0031959 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.3 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.1 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 1.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 7.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.7 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 1.0 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.4 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.4 | GO:0061744 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
0.1 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 1.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.1 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 4.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.3 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.1 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.7 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 1.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 6.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.3 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.2 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.1 | 0.3 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 0.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.1 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 1.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.5 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.3 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 1.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.1 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.7 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.1 | 0.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.4 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.0 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.3 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 1.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.5 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.0 | 2.9 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
0.0 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.1 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.0 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 1.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.2 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.0 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.0 | GO:0032571 | response to vitamin K(GO:0032571) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 1.0 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 1.0 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.3 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.0 | 0.0 | GO:0021539 | subthalamus development(GO:0021539) |
0.0 | 0.1 | GO:0006788 | heme oxidation(GO:0006788) |
0.0 | 1.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.6 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.1 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) |
0.0 | 0.8 | GO:0048634 | regulation of muscle organ development(GO:0048634) |
0.0 | 0.0 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.0 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.0 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.0 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.0 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 1.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.5 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 2.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.0 | 0.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.4 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 3.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0031646 | positive regulation of neurological system process(GO:0031646) positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 2.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.5 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.7 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.2 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.6 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.0 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 1.6 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.0 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.0 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.1 | GO:0003335 | corneocyte development(GO:0003335) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 0.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.0 | 0.1 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.6 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.2 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.0 | 0.0 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.2 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 1.1 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.0 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
1.3 | 12.1 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 3.2 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
1.1 | 3.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.0 | 16.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.0 | 4.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.9 | 0.9 | GO:0044094 | viral replication complex(GO:0019034) host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.8 | 3.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 5.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.8 | 0.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.8 | 21.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 6.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 10.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 2.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 3.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 1.9 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.6 | 3.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 13.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 3.0 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.6 | 13.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.6 | 0.6 | GO:0000806 | Y chromosome(GO:0000806) |
0.6 | 5.8 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 2.8 | GO:0032449 | CBM complex(GO:0032449) |
0.6 | 6.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 2.2 | GO:0097196 | Shu complex(GO:0097196) |
0.5 | 3.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 2.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.5 | 2.0 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.5 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.5 | GO:0055028 | cortical microtubule(GO:0055028) |
0.5 | 5.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 4.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 1.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.5 | 3.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.5 | 1.9 | GO:0001740 | X chromosome(GO:0000805) Barr body(GO:0001740) |
0.5 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.5 | 2.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 4.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.4 | 3.8 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 4.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 4.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 2.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.4 | 1.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.4 | 1.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 1.2 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.4 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.4 | 1.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 3.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 5.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 1.4 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.3 | 9.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 10.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 2.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.3 | 2.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.0 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.3 | 2.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.3 | 2.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 2.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 10.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 4.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 11.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 0.6 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.3 | 0.9 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.3 | 1.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 3.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 8.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 4.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 2.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 3.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 3.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 0.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 4.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 1.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 1.0 | GO:0031673 | H zone(GO:0031673) |
0.2 | 0.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 1.0 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 1.0 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 13.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 3.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.2 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 1.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 14.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.4 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 3.5 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 3.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 5.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 8.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 1.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 6.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 16.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 4.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 6.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 2.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.6 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.2 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 2.8 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 2.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 15.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 3.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 6.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 1.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 2.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 10.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 0.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.9 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.9 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 2.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 4.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 2.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 1.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 7.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 16.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.1 | 1.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 2.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 22.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 12.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 0.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.1 | 3.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 3.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.5 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 2.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 2.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 5.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 2.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 7.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 10.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 4.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 2.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 6.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 12.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 44.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.1 | 2.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 1.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.1 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.1 | 0.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 13.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 4.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.3 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.1 | 2.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0005715 | late recombination nodule(GO:0005715) |
0.1 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.1 | 4.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.1 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 2.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 7.7 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.9 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.9 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 2.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 5.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 4.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 2.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.1 | GO:1990462 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 4.0 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 4.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 23.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 3.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 1.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.3 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 3.9 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.0 | 2.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 4.3 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 7.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 1.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 4.6 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 5.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.7 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 1.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 5.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.4 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 33.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
2.6 | 7.9 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
1.8 | 8.8 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
1.7 | 8.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.7 | 5.1 | GO:0004103 | choline kinase activity(GO:0004103) |
1.6 | 4.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
1.6 | 6.3 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.5 | 4.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.4 | 8.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.4 | 4.2 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
1.4 | 6.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.3 | 5.3 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
1.3 | 3.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.2 | 12.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.2 | 13.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.2 | 3.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.1 | 4.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.1 | 5.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.1 | 9.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 3.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
1.0 | 7.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.0 | 3.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.9 | 3.8 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.9 | 5.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.9 | 15.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 5.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.9 | 3.6 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.9 | 2.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.8 | 3.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.8 | 5.0 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.8 | 4.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 5.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 3.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.8 | 2.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.8 | 3.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 3.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.8 | 6.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.8 | 21.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 3.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 3.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 11.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 3.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.7 | 2.2 | GO:0052825 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.7 | 2.2 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.7 | 5.8 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 4.3 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.7 | 2.8 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 6.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 2.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 2.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.0 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.7 | 7.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 1.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 5.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 2.5 | GO:0008431 | vitamin E binding(GO:0008431) |
0.6 | 7.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 1.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.6 | 2.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 2.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.6 | 1.8 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.6 | 2.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.6 | 2.3 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.6 | 3.5 | GO:0039552 | RIG-I binding(GO:0039552) |
0.6 | 2.9 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.6 | 1.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.6 | 6.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.6 | 7.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 1.7 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.6 | 9.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 7.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 4.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 3.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 2.8 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.6 | 1.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.5 | 4.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 2.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.5 | 1.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 1.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.5 | 2.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.5 | 2.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 3.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 1.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 4.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 2.6 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.5 | 15.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 3.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 5.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 1.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 3.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 4.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.5 | 5.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 6.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 1.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 3.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 9.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 7.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 5.0 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.4 | 5.4 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 11.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.8 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.4 | 6.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 2.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 14.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 2.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 11.5 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 2.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.4 | 2.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.4 | 1.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.4 | 5.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 1.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.4 | 1.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.4 | 1.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.6 | GO:1903135 | cupric ion binding(GO:1903135) |
0.4 | 1.6 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.4 | 2.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 2.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 2.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 1.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 3.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 1.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.4 | 5.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 1.5 | GO:0047708 | biotinidase activity(GO:0047708) |
0.4 | 0.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.4 | 4.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 5.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 1.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.4 | 1.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.4 | 1.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.4 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 1.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.4 | 8.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.1 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.4 | 2.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 1.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.4 | 1.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.4 | 2.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 4.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 4.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 2.2 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.4 | 1.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 1.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.4 | 1.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.4 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 1.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 1.8 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.4 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 2.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.0 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 1.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 0.3 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) |
0.3 | 2.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 4.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 2.6 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 2.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.3 | 2.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 2.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 2.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.3 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.3 | 0.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.3 | 2.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.9 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 0.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.3 | 2.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.3 | 5.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 5.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 8.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 5.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 36.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.3 | 2.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 1.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 1.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.3 | 0.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 1.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.9 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.3 | 11.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 5.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 3.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 0.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 1.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 0.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 1.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 0.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.3 | 0.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.3 | 1.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.3 | 0.8 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.3 | 3.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 1.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 6.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 1.6 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 1.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 1.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 1.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 2.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 8.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.3 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.3 | GO:0070404 | NADH binding(GO:0070404) |
0.3 | 1.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.2 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 4.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 2.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.7 | GO:0090541 | MIT domain binding(GO:0090541) |
0.2 | 1.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 2.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 2.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 0.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 1.6 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 0.9 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 0.7 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.2 | 0.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 1.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.2 | 0.7 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.2 | 1.8 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 1.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 3.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 3.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 2.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 3.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 5.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.4 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.2 | 1.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 4.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 5.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.2 | 0.2 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 1.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 3.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 2.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 2.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 3.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 1.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 0.8 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 2.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 4.1 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 2.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 2.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.4 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 1.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 1.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.9 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.2 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.6 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.2 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.2 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 2.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.2 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 6.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.8 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 1.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 2.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.3 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.2 | 2.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 7.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.5 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.2 | 0.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 3.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 8.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 1.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 6.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 0.4 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 7.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 3.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 9.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 2.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.1 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 2.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 6.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 2.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 2.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 2.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 4.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 0.4 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 1.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.6 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 1.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 1.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.5 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 2.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 2.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 2.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 5.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 17.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 3.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 2.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 3.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 39.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 5.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.6 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 1.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.9 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) rhodopsin kinase activity(GO:0050254) |
0.1 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 1.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.3 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 1.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 2.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 3.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.8 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 1.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 7.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 3.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 7.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 2.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 3.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
0.1 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 3.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.1 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 1.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 2.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 2.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 1.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 5.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 1.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.1 | 0.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 2.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 23.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 3.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.6 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.1 | GO:0032557 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 42.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 1.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.2 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.0 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 3.3 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 3.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 2.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.0 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 2.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.7 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 1.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 1.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 4.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.7 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.0 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.0 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 3.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 1.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 1.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 2.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.9 | 54.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.8 | 3.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 3.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 6.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 9.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 2.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 38.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 26.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 5.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 6.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 8.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 9.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 5.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 8.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 9.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 17.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 30.5 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 6.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 9.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 4.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 3.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 5.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 3.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 4.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 6.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 10.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 6.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 3.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 7.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 7.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 16.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 9.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 8.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 11.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 5.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 2.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 4.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 18.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 2.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 2.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 2.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 3.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 1.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 12.5 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.7 | 2.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 3.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 0.6 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 14.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.6 | 9.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 22.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 16.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 11.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 12.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 12.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 22.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 15.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 7.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 4.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 9.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 4.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 12.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 9.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 5.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 6.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 8.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 6.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 4.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 15.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 7.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 4.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 16.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 5.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 7.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 5.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 6.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 5.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 2.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 2.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 18.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 2.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 4.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 5.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 11.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 6.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.8 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 1.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 11.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 5.9 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 5.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 3.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 2.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 2.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 3.0 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 9.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 2.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 3.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 3.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 3.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 6.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 3.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 4.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 2.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 2.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 1.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 5.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 2.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 2.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |